DUBLIN--(BUSINESS WIRE)--The "Competing in the Global Coagulation Testing Market, 2017-2021" report has been added to Research and Markets' offering.
This comprehensive seven-country report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the coagulation market during the next five years.
The report explores business and technological trends in the US, five major European countries (France, Germany, Italy, Spain, UK) and Japan; provides estimates of the test volume, instrument placements and installed base, as well as sales and market shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.
The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromagenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, computers and laboratory automation will radically change the coagulation testing practice during the next five years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation.
Coagulation testing will also become more standardized, offering opportunities for quality control products and services. Moreover, continuing contraction of the hospital system and technological advances will facilitate decentralization of the coagulation testing closer to the patient, thus creating additional opportunities and challenges for suppliers.
- ADI/American Diagnostica/Sekisui
- Beckman Coulter/Danaher
- Becton Dickinson
- Bio/Data Corporation
- Corgenix Medical
- Diagnostica Stago/Trinity Biotech
- Helena Laboratories
- HYPEN BioMed
- Instrumentation Laboratory
- Thermo Fisher
For more information about this report visit https://www.researchandmarkets.com/research/38f5pv/competing_in_the.